Abstract
Despite advances in neuro-imaging, neurosurgery, radiation therapy, and chemotherapy, limited progress has been made in the treatment of patients with high-grade astrocytomas. Primary brain tumours are considered to be among the most difficult neoplasms to treat which is largely due to the invasive nature of these tumours and the complexity of the organ in which they arise. In an attempt to overcome some of the limitations of systemic delivery of anticancer drugs, several methods of localised delivery have been developed. In this article we briefly review some of the current literature on systems for localised delivery of therapeutic agents to brain tumors, which consists of osmotic mini-pumps, infusion pumps (convectionenhanced delivery), and cell grafting. Furthermore, special emphasis is made on bio-degradable polymers, which is at present the best characterised system of local delivery to brain tumors, along with a promising novel delivery system, based on non-degradable polymer encapsulated cell therapy.
Keywords: Localised Delivery, CNS Malignancies, neuro-imaging, astrocytomas, bio-degradable polymers, cell therapy, osmotic mini-pumps, cell grafting, polymer matrix
Current Pharmaceutical Biotechnology
Title: Localised Delivery of Therapeutic Agents to CNS Malignancies: Old and New Approaches
Volume: 3 Issue: 3
Author(s): Tracy-Ann Read, Frits Thorsen and Rolf Bjerkvig
Affiliation:
Keywords: Localised Delivery, CNS Malignancies, neuro-imaging, astrocytomas, bio-degradable polymers, cell therapy, osmotic mini-pumps, cell grafting, polymer matrix
Abstract: Despite advances in neuro-imaging, neurosurgery, radiation therapy, and chemotherapy, limited progress has been made in the treatment of patients with high-grade astrocytomas. Primary brain tumours are considered to be among the most difficult neoplasms to treat which is largely due to the invasive nature of these tumours and the complexity of the organ in which they arise. In an attempt to overcome some of the limitations of systemic delivery of anticancer drugs, several methods of localised delivery have been developed. In this article we briefly review some of the current literature on systems for localised delivery of therapeutic agents to brain tumors, which consists of osmotic mini-pumps, infusion pumps (convectionenhanced delivery), and cell grafting. Furthermore, special emphasis is made on bio-degradable polymers, which is at present the best characterised system of local delivery to brain tumors, along with a promising novel delivery system, based on non-degradable polymer encapsulated cell therapy.
Export Options
About this article
Cite this article as:
Read Tracy-Ann, Thorsen Frits and Bjerkvig Rolf, Localised Delivery of Therapeutic Agents to CNS Malignancies: Old and New Approaches, Current Pharmaceutical Biotechnology 2002; 3 (3) . https://dx.doi.org/10.2174/1389201023378346
DOI https://dx.doi.org/10.2174/1389201023378346 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alpha-Interferon and Its Effects on Signalling Pathways Within Cells
Current Protein & Peptide Science The Application of Peptides in Glioma: A Novel Tool for Therapy
Current Pharmaceutical Biotechnology Anticancer Vitamin K3 Analogs: A Review
Anti-Cancer Agents in Medicinal Chemistry Targeting Angiogenesis for Treatment of NSCLC Brain Metastases
Current Cancer Drug Targets Resveratrol and Cancer Treatment: Is Hormesis a Yet Unsolved Matter?
Current Pharmaceutical Design Trophoblast Invasion: A Possible Link Between Implantation Deficiencies and Preeclampsia
Current Women`s Health Reviews Aquaporins and Roles in Brain Health and Brain Injury
Mini-Reviews in Medicinal Chemistry Amyloid Precursor Protein Processing in Vivo - Insights from a Chemically- Induced Constitutive Overactivation of Protein Kinase C in Guinea Pig Brain
Current Medicinal Chemistry Realization Methods of Computer-aided Diagnosis System of Medical Images
Recent Patents on Engineering The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine Modulation of Matrix Metalloproteinases by Plant-derived Products
Current Cancer Drug Targets Poly (ADP-Ribosyl) Polymerase 1 Inhibitors: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery Advances in Oncolytic Virus Therapy for Glioma
Recent Patents on CNS Drug Discovery (Discontinued) Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies
Current Neuropharmacology New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Ionotropic Glutamate Receptors & CNS Disorders
CNS & Neurological Disorders - Drug Targets Perspectives on Brain-Targeting Drug Delivery Systems
Current Pharmaceutical Biotechnology Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
Current Protein & Peptide Science Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy
Current Cancer Therapy Reviews